[Angiogenesis-targeted therapy: therapeutic potential for neurosurgical disorders].
Abe
Tatsuya
T
Department of Neurosurgery, Oita University Faculty of Medicine, Idaigaoka 1-1, Hasama, Yufu, Oita 879-5593, Japan.
Kamida
Tohru
T
Fujiki
Minoru
M
Kobayashi
Hidenori
H
D042682:Angiopoietins / Q000502:physiology; D000818:Animals; D042783:Endothelial Cells / Q000502:physiology; D036388:Ephrin-B2 / Q000502:physiology; D009131:Muscle, Smooth, Vascular / Q000502:physiology; D009389:Neovascularization, Pathologic / Q000503:physiopathology / Q000628:therapy; D018919:Neovascularization, Physiologic / Q000502:physiology*; D036224:Receptor, EphB4 / Q000502:physiology; D042787:Receptor, TIE-2 / Q000502:physiology; D040262:Receptors, Vascular Endothelial Growth Factor / Q000502:physiology; D042461:Vascular Endothelial Growth Factor A / Q000502:physiology
D042682:Angiopoietins; D036388:Ephrin-B2; D042461:Vascular Endothelial Growth Factor A; D036224:Receptor, EphB4; D042787:Receptor, TIE-2; D040262:Receptors, Vascular Endothelial Growth Factor